Zeolite-based organized molecular assemblies. photophysical characterization and documentation of donor oxidation upon photosensitized charge separation

An organized molecular assembly composed of two ruthenium polypyridine complexes, Ru(bpy)(2)(bpz)(2+) and Ru(bpy)(2)(H(2)O)(2)(2+) (where bpy = 2, 2'-bipyridine and bpz = 2, 2'-bipyrazine), has been prepared in adjacent supercages of Y-zeolite. This material has been characterized by diffuse reflectance, electronic absorption, electronic emission, and resonance Raman (RR) spectroscopy, as well as lifetime measurements. The spectral results confirm the identity of the entrapped complexes and resonance Raman measurements show that the relative concentrations of the two complexes within the zeolite particles are identical. A dramatic decrease in emission intensity observed for the adjacent cage assembly, relative to that observed for an appropriate reference material composed of a mixture of zeolite particles containing the separated complexes, indicates strong interaction between the adjacent complexes which provides an additional nonradiative decay pathway. The excited state lifetime measurements implicate a very short-lived component, dominating the decay curve at early times, which is most reasonably attributed to excited-state electron-transfer quenching of the adjacent cage pair. More importantly, analysis of diffuse reflectance spectra acquired during selective (sensitizer) irradiation of a sample of this material, wherein the remaining cages are filled with a suitable acceptor (MV(2+)), provides direct evidence for oxidation of the Ru(bpy)(2)(H(2)O)(2)(2+) donor complex, confirming the targeted synergy of the adjacent cage assembly.     

High order assembly of multiple protein cages with homogeneous sizes and shapes via limited cage surface engineering

Protein cages are attractive building blocks to build high order materials such as 3D cage lattices, which offer accurately ordered bio-templates. However, controlling the size or valency of these cage-to-cage assemblies is extremely difficult due to highly multivalent and symmetric cage structures. Here, various high order cage assemblies with homogeneous sizes and geometries are constructed by developing an anisotropic ferritin cage with limitedly exposed binding modules, leucine zipper. The anisotropic ferritin is produced as expressed in cells without the need of complex in vitro cage fabrication by careful subunit manipulation. Ferritin cages with limitedly exposed zippers are assembled around a core ferritin with fully exposed opposing zippers, generating homogeneous high order structures, whereas two fully exposed ferritins are assembled into heterogeneous cage aggregates. Diverse fully exposed core cages are prepared by varying the zipper-ferritin fusion geometries and even by using larger cage structures. With these core cages and the anisotropic ferritin, a range of high order cage assemblies with diverse ferritin valencies (3 to over 12) and sizes (over 40 nm) are created. Cell surface binding and internalization of cage structures are greatly varied by assembly sizes, where high order ferritins are clearly more effective than monomeric ferritin.

Diverse high order protein cage structures with homogeneous sizes and shapes were assembled with anisotropic ferritin cages with limitedly exposed binding modules.     

Construction of Matryoshka‐Type Structures from Supercharged Protein Nanocages

Designing nanoscaled hierarchical structures with increasing levels of complexity is challenging. Here we show that electrostatic interactions between two complementarily supercharged protein nanocages can be effectively utilized to create nested Matryoshka‐type structures. Cage‐within‐cage complexes containing spatially ordered iron oxide nanoparticles spontaneously self‐assemble upon mixing positively supercharged ferritin compartments with AaLS‐13, a larger shell‐forming protein with a negatively supercharged lumen. Exploiting engineered Coulombic interactions and protein dynamics in this way opens up new avenues for creating hierarchically organized supramolecular assemblies for application as delivery vehicles, reaction chambers, and artificial organelles.     

Cellular delivery of pyrenyl-arene ruthenium complexes by a water-soluble arene ruthenium metalla-cage

Three pyrenyl-arene ruthenium complexes (M(1)-M(3)) of the general formula [Ru(η(6)-arene-pyrenyl)Cl(2)(pta)] (pta = 1,3,5-triaza-7-phosphaadamantane) have been synthesised and characterised. Prior to the coordination to ruthenium, pyrene was connected to the arene ligand via an alkane chain containing different functional groups: ester (L(1)), ether (L(2)) and amide (L(3)), respectively. Furthermore, the pyrenyl moieties of the M(n) complexes were encapsulated within the hydrophobic cavity of the water soluble metalla-cage, [Ru(6)(η(6)-p-cymene)(6)(tpt)(2)(donq)(3)](6+) (tpt = 2,4,6-tri-(pyridin-4-yl)-1,3,5-triazine; donq = 5,8-dioxydo-1,4-naphthoquinonato), while the arene ruthenium end was pointing out of the cage, thus giving rise to the corresponding host-guest systems [M(n)?Ru(6)(η(6)-p-cymene)(6)(tpt)(2)(donq)(3)](6+) ([M(n)?cage](6+)). The antitumor activity of the pyrenyl-arene ruthenium complexes (M(n)) and the corresponding host-guest systems [M(n)?cage][CF(3)SO(3)](6) were evaluated in vitro in different types of human cancer cell lines (A549, A2780, A2780cisR, Me300 and HeLa). Complex M(2), which contains an ether group within the alkane chain, demonstrated at least a 10 times higher cytotoxicity than the reference compound [Ru(η(6)-p-cymene)Cl(2)(pta)] (RAPTA-C). All host-guest systems [M(n)?cage](6+) showed good anticancer activity with IC(50) values ranging from 2 to 8 μM after 72 h exposure. The fluorescence of the pyrenyl moiety allowed the monitoring of the cellular uptake and revealed an increase of uptake by a factor two of the M(2) complex when encapsulated in the metalla-cage [Ru(6)(η(6)-p-cymene)(6)(tpt)(2)(donq)(3)](6+).     

Engineered protein cages for nanomaterial synthesis

Self-assembled particles of genetically engineered human L subunit ferritin expressing a silver-binding peptide were used as nanocontainers for the synthesis of silver nanoparticles. The inner cavity of the self-assembled protein cage displays a dodecapeptide that is capable of reducing silver ions to metallic silver. This chimeric protein cage when incubated in the presence of silver nitrate exhibits the growth of a silver nanocrystal within its cavity. Our studies indicate that it is possible to design chimeric cages, using specific peptide templates, for the growth of other inorganic nanoparticles.     

Photocatalytic synthesis of copper colloids from CuII by the ferrihydrite core of ferritin

The iron-storage protein ferritin encapsulates a nanoparticle of iron oxide. The size and properties of these nanoparticles can be adjusted by controlled oxidative hydrolysis reactions of Fe(II). This mineralized ferritin protein cage has previously been shown to act as an effective photocatalyst for reduction of Cr(VI). In the present work, we demonstrate that Fe(O)OH-mineralized ferritin catalyzes the photoreduction of Cu(II) to form a stable, air-sensitive, colloidal dispersion of Cu(0). In addition, the particle sizes of the Cu colloids can be controlled by varying the ratio of Cu(II) to ferritin. This illustrates an important principle, namely that the properties of one preformed material can be utilized for the specific synthesis of a second material, thus tailoring the desired physical properties of the final products. This procedure represents a multistep materials synthesis: the formation of a new nanomaterial from a catalytic precursor.     

A Photoactive Carbon‐Monoxide‐Releasing Protein Cage for Dose‐Regulated Delivery in Living Cells

Protein cages can serve as bioinorganic molecular templates for functionalizing metal compounds to regulate cellular signaling. We succeeded in developing a photoactive CO‐releasing system by constructing a composite of ferritin (Fr) containing manganese–carbonyl complexes. When Arg52 adjacent to Cys48 of Fr is replaced with Cys, the Fr mutant stabilizes the retention of 48 Mn–carbonyl moieties, which can release the CO ligands under light irradiation, although wild‐type Fr retains very few Mn moieties. The amount of released CO is regulated by the extent of irradiation. This could reveal an optimized dose for cooperatively activating the nuclear factor κB (NF‐κB) in mammalian cells and the tumor necrosis factor α (TNF‐α). These results suggest that construction of a CO‐releasing protein cage will advance of research in CO biology.     

Hydrogen-mediated metal-carbon to metal-boron bond conversion in metal-carboranyl complexes

A hydrogen-mediated Ru-C to Ru-B bond conversion was observed experimentally and supported by the theoretical calculations. Treatment of [eta(5):sigma(C)-Me(2)C(C(5)H(4))(C(2)B(10)H(10))]Ru(COD) (1) bearing a Ru-C(cage) sigma bond with PR(3) in the presence of H(2) gave Ru-B(cage) bonded complexes [eta(5):sigma(B)-Me(2)C(C(5)H(4))(C(2)B(10)H(10))]RuH(2)(PR(3)) (R = Cy (2), Ph (3)) (sigma(C): Ru-C(cage) sigma bond; sigma(B): Ru-B(cage) sigma bond). Complex 3 was converted to [eta(5):sigma(B)-Me(2)C(C(5)H(4))(C(2)B(10)H(10))]Ru(L(2)) in the presence of L(2) (L(2) = dppe (4), PPh(3)/P(OEt)(3) (5), PPh(3)/pyridine (6)) via liberation of H(2) upon heating. These complexes were fully characterized by various spectroscopic techniques, elemental analyses, and single-crystal X-ray diffraction studies. DFT calculations show that this conversion process is both kinetically and thermodynamically favorable and requires involvement of a hydride ligand.     

Enzyme Encapsulation by a Ferritin Cage

Ferritins, conserved across all kingdoms of life, are protein nanocages that evolved to mineralize iron. The last several decades have shown that these cages have considerable technological and medical potential owing to their stability and tolerance to modification, as well as their ability to template nanoparticle synthesis and incorporate small molecules. Here we show that it is possible to encapsulate proteins in a ferritin cage by exploiting electrostatic interactions with its negatively charged interior. Positively supercharged green fluorescent protein is efficiently taken up by Archaeoglobus fulgidus ferritin in a tunable fashion. Moreover, several enzymes were readily incorporated when genetically tethered to this fluorescent protein. These fusion proteins retained high catalytic activity and showed increased tolerance to proteolysis and heat. Equipping ferritins with enzymatic activity paves the way for many new nanotechnological and pharmacological applications.     

Targeting of cancer cells with ferrimagnetic ferritin cage nanoparticles

Protein cage architectures such as virus capsids and ferritins are versatile nanoscale platforms amenable to both genetic and chemical modification. Incorporation of multiple functionalities within these nanometer-sized protein architectures demonstrate their potential to serve as functional nanomaterials with applications in medical imaging and therapy. In the present study, we synthesized an iron oxide (magnetite) nanoparticle within the interior cavity of a genetically engineered human H-chain ferritin (HFn). A cell-specific targeting peptide, RGD-4C which binds alphavbeta3 integrins upregulated on tumor vasculature, was genetically incorporated on the exterior surface of HFn. Both magnetite-containing and fluorescently labeled RGD4C-Fn cages bound C32 melanoma cells in vitro. Together these results demonstrate the capability of a genetically modified protein cage architecture to serve as a multifunctional nanoscale container for simultaneous iron oxide loading and cell-specific targeting.     

Iron Biomineral Growth from the Initial Nucleation Seed in L-Ferritin

X-ray structures of homopolymeric human L -ferritin and horse spleen ferritin were solved by freezing protein crystals at different time intervals after exposure to a ferric salt and revealed the growth of an octa-nuclear iron cluster on the inner surface of the protein cage with a key role played by some glutamate residues. An atomic resolution view of how the cluster formation develops starting from a (μ³-oxo)tris[(μ²-glutamato-κO:κO’)](glutamato-κO)(diaquo)triiron(III) seed is provided. The results support the idea that iron biomineralization in ferritin is a process initiating at the level of the protein surface, capable of contributing coordination bonds and electrostatic guidance.     

Four‐fold Channel‐Nicked Human Ferritin Nanocages for Active Drug Loading and pH‐Responsive Drug Release

Human ferritins are emerging platforms for non‐toxic protein‐based drug delivery, owing to their intrinsic or acquirable targeting abilities to cancer cells and hollow cage structures for drug loading. However, reliable strategies for high‐level drug encapsulation within ferritin cavities and prompt cellular drug release are still lacking. Ferritin nanocages were developed with partially opened hydrophobic channels, which provide stable routes for spontaneous and highly accumulated loading of Fe^II‐conjugated drugs as well as pH‐responsive rapid drug release at endoplasmic pH. Multiple cancer‐related compounds, such as doxorubicin, curcumin, and quercetin, were actively and heavily loaded onto the prepared nicked ferritin. Drugs on these minimally modified ferritins were effectively delivered inside cancer cells with high toxicity.     

Eilatin as a bridging ligand in ruthenium(II) complexes: synthesis,crystal structures,absorption spectra,and electrochemical properties

The potential of the heptacyclic aromatic alkaloid eilatin (1), that features two nonequivalent binding sites, to serve as a bridging ligand is reported. The nonequivalency of the binding sites allowed the selective synthesis of both mono- and dinuclear complexes. The mononuclear Ru(II) complexes [Ru(dmbpy)(2)(eilatin)](2+) (2) and [Ru(tmbpy)(2)(eilatin)](2+) (3) in which eilatin selectively binds "head-on" were synthesized and employed as building blocks in the synthesis of the dinuclear complexes [[Ru(dmbpy)(2)](2)(mu-eilatin)](4+) (4) and [[Ru(tmbpy)(2)](2)(mu-eilatin)](4+) (5). Complete structure elucidation of the complexes in solution was accomplished by 1D and 2D NMR techniques. The X-ray structures of the mononuclear complex 3 and of the two dinuclear complexes 4 and 5 were solved, and absorption spectra and electrochemical properties of the complexes were explored. Both dinuclear complexes formed as racemic mixtures in a 3:1 diastereoisomeric ratio, the major isomer being the heterochiral one (Delta Lambda/Lambda Delta) as revealed by crystallography. The mononuclear complexes feature an exceptionally low energy MLCT band around 600 nm that shifted to over 700 nm upon the binding of the second Ru(II) center. The mononuclear complexes show one reversible oxidation and several reversible reduction waves, the first two reductions being substantially anodically shifted in comparison with [Ru(bpy)(3)](2+), attributed to the reduction of eilatin, and consistent with its low lying pi* orbital. The dinuclear complexes follow the same reduction trend, exhibiting several reversible reduction waves, and two reversible well-resolved metal centered oxidations due to the nonequivalent binding sites and to a significant metal-metal interaction mediated by the bridging eilatin.     

Photochemical activation of ruthenium(II)-pyridylamine complexes having a pyridine-N-oxide pendant toward oxygenation of organic substrates

Ruthenium(II)-acetonitrile complexes having η(3)-tris(2-pyridylmethyl)amine (TPA) with an uncoordinated pyridine ring and diimine such as 2,2'-bipyridine (bpy) and 2,2'-bipyrimidine (bpm), [Ru(II)(η(3)-TPA)(diimine)(CH(3)CN)](2+), reacted with m-chloroperbenzoic acid to afford corresponding Ru(II)-acetonitrile complexes having an uncoordinated pyridine-N-oxide arm, [Ru(II)(η(3)-TPA-O)(diimine)(CH(3)CN)](2+), with retention of the coordination environment. Photoirradiation of the acetonitrile complexes having diimine and the η(3)-TPA with the uncoordinated pyridine-N-oxide arm afforded a mixture of [Ru(II)(TPA)(diimine)](2+), intermediate-spin (S = 1) Ru(IV)-oxo complex with uncoordinated pyridine arm, and intermediate-spin Ru(IV)-oxo complex with uncoordinated pyridine-N-oxide arm. A Ru(II) complex bearing an oxygen-bound pyridine-N-oxide as a ligand and bpm as a diimine ligand was also obtained, and its crystal structure was determined by X-ray crystallography. Femtosecond laser flash photolysis of the isolated O-coordinated Ru(II)-pyridine-N-oxide complex has been investigated to reveal the photodynamics. The Ru(IV)-oxo complex with an uncoordinated pyridine moiety was alternatively prepared by reaction of the corresponding acetonitrile complex with 2,6-dichloropyridine-N-oxide (Cl(2)py-O) to identify the Ru(IV)-oxo species. The formation of Ru(IV)-oxo complexes was concluded to proceed via intermolecular oxygen atom transfer from the uncoordinated pyridine-N-oxide to a Ru(II) center on the basis of the results of the reaction with Cl(2)py-O and the concentration dependence of the consumption of the starting Ru(II) complexes having the uncoordinated pyridine-N-oxide moiety. Oxygenation reactions of organic substrates by [Ru(II)(η(3)-TPA-O)(diimine)(CH(3)CN)](2+) were examined under irradiation (at 420 ± 5 nm) and showed selective allylic oxygenation of cyclohexene to give cyclohexen-1-ol and cyclohexen-1-one and cumene oxygenation to afford cumyl alcohol and acetophenone.     

Luminescent lanthanide complexes as analytical tools in anion sensing, pH indication and protein recognition

Although lanthanide complexes are recently used in luminescence labeling of bio-targets, this review focuses on sensing profiles of synthetic and biological lanthanide complexes. Rational design and combinatorial screening approaches toward synthetic lanthanide complexes applicable as luminescent sensing materials are described. Iron-carrying transferrin and ferritin proteins further form lanthanide complexes working as pH indicators and protein recognition reagents.     

Ruthenium(II)/(III) complexes of 4-hydroxy-pyridine-2,6-dicarboxylic acid with PPh3/AsPh3 as co-ligand: impact of oxidation state and co-ligands on anticancer activity in vitro

With the aim to develop more efficient, less toxic, target specific metal drugs and evaluate their anticancer properties in terms of oxidation state and co-ligand sphere, a sequence of Ru(II), Ru(III) complexes bearing 4-hydroxy-pyridine-2,6-dicarboxylic acid and PPh(3)/AsPh(3) were synthesized and structurally characterized. Biological studies such as DNA binding, antioxidant assays and cytotoxic activity were carried out and their anticancer activities were evaluated. Interactions of the complexes with calf thymus DNA revealed that the triphenylphosphine complexes could bind more strongly than the triphenylarsine complexes. The free radical scavenging ability, assessed by a series of in vitro antioxidant assays involving DPPH radical, hydroxyl radical, nitric oxide radical, superoxide anion radical, hydrogen peroxide and metal chelating assay, showed that the Ru(III) complexes possess excellent radical scavenging properties compared to those of Ru(II). Cytotoxicity studies using three cancer lines viz HeLa, HepG2, HEp-2 and a normal cell line NIH 3T3 showed that Ru(II) complexes exhibited substantial cytotoxic specificity towards cancer cells. Furthermore, the Ru(II) complexes were found to be superior to Ru(III) complexes in inhibiting the growth of cancer cells.     

Synthesis, anticancer and antibacterial activity of some novel mononuclear Ru(II) complexes

In search of potential anticancer drug candidates in ruthenium complexes, a series of mononuclear ruthenium complexes of the type [Ru(phen)(2)(nmit)]Cl(2) (Ru1), [Ru(bpy)(2)(nmit)]Cl(2) (Ru2), [Ru(phen)(2)(icpl)]Cl(2) (Ru3), Ru(bpy)(2)(icpl)]Cl(2) (Ru4) (phen=1,10-phenanthroline; bpy=2,2'-bipyridine; nmit=N-methyl-isatin-3-thiosemicarbazone, icpl=isatin-3-(4-Cl-phenyl)thiosemicarbazone) and [Ru(phen)(2)(aze)]Cl(2) (Ru5), [Ru(bpy)(2)(aze)]Cl(2) (Ru6) (aze=acetazolamide) and [Ru(phen)(2)(R-tsc)](ClO(4))(2) (R=methyl (Ru7), ethyl (Ru8), cyclohexyl (Ru9), 4-Cl-phenyl (10), 4-Br-phenyl (Ru11), and 4-EtO-phenyl (Ru12), tsc=thiosemicarbazone) were prepared and characterized by elemental analysis, FTIR, (1)H-NMR and FAB-MS. Effect of these complexes on the growth of a transplantable murine tumor cell line (Ehrlich Ascites Carcinoma) and their antibacterial activity were studied. In cancer study the effect of hematological profile of the tumor hosts have also been studied. In the cancer study, the complexes Ru1-Ru4, Ru10 and Ru11 have remarkably decreased the tumor volume and viable ascitic cell count as indicated by trypan blue dye exclusion test (p<0.05). Treatment with the ruthenium complexes prolonged the lifespan of Ehrlich Ascites Carcinoma (EAC) bearing mice. Tumor inhibition by the ruthenium chelates was followed by improvements in hemoglobin, RBC and WBC values. All the complexes showed antibacterial activity, except Ru5 and Ru6. Thus, the results suggest that these ruthenium complexes have significant antitumor property and antibacterial activity. The results also reflect that the drug does not adversely affect the hematological profiles as compared to that of cisplatin on the host.     

Photolysis of (Diamine)bis(2,2'-bipyridine)ruthenium(II) Complexes Using On-Line Electrospray Mass Spectrometry

Photolysis of Ru(bpy)(2)(en)(2+) and Ru(bpy)(2)(tn)(2+), where bpy = 2,2'-bipyridine, en = ethylenediamine, and tn = 1,3-propylenediamine, was studied in acetonitrile using on-line electrospray mass spectrometry (ES-MS). These complexes are known to undergo a four-electron oxidation photochemically, giving the alpha,alpha'-diimine complexes. The monoimine complexes involved in this stepwise process were detectable after photoirradiation (lambda >420 nm). Also, new ligand-oxidized complexes Ru(bpy)(2)(en+14)(2+) and Ru(bpy)(2)(tn+14)(2+) were observed together with photosubstitution products such as Ru(bpy)(2)(AN)(2)(2+) and Ru(bpy)(2)(AN)(2)X(+) (AN = acetonitrile). The notation (en+14) and (tn+14) represents loss of two hydrogen atoms and addition of an oxygen atom to the en and tn ligands. Photosubstitution intermediates with the monodentate diamine, Ru(bpy)(2)(tn)(AN)(2+) and Ru(bpy)(2)(tn)(AN)X(+), were detected in the ES mass spectrum of the tn complex but not in that of the en complex. Other photosubstituted intermediates with the monodentate (en+14) and (tn+14) ligands were detected by on-line mass analysis. The electrospray technique combined with use of a flow-through photoreaction cell was shown to be a useful tool for studying photolysis of inorganic metal complexes.     

Syntheses of homochiral multinuclear ru complexes based on oligomeric bibenzimidazoles

The homochiral multinuclear Ru complexes of the oligomeric bibenzimidazoles were synthesized using Lambda-[Ru(bpy)2(py)2][(-)-O,O'-dibenzoyl-l-tartrate].12H2O as an enantiomerically pure building block. The complexations proceed with the retention of configuration to provide well-defined mononuclear, dinuclear, tetranuclear, and octanuclear Ru complexes successfully. The optical purity and the absolute configurations of the complexes were determined by NMR and circular dichroism spectrometry. The rare X-ray structure of a tetranuclear complex Lambda4-[(Ru(bpy)2)4(bis(BiBzIm))](PF6)4 was resolved. The crystallographic analysis reveals that all the four Ru centers have Lambda octahedral configurations, with a Ru-Ru separation of 5.509 A across the bridging bibenzimidazole ligand, which maintains near coplanarity. The UV-vis spectroscopic and electrochemical properties of the homochiral multinuclear assemblies were studied, indicating weak electronic communications between the metal centers.     

Binding of antitumor ruthenium complexes to DNA and proteins: a theoretical approach

The thermodynamics of the binding of the antitumor ammine, amine, and immine complexes of ruthenium(II) and ruthenium(III) to DNA and peptides was studied computationally using model molecules. We performed density functional calculations on several monofunctional ruthenium complexes of the formula [Ru(NH3)5B]z+, where B is an adenine, guanine, or cytosine nucleobase or an 4-methylimidazole, a dimethylthioether, or a dimethylphosphate anion and z = 2 and 3. The pentammineruthenium fragment has been intensively studied and also constitutes a good model for a wide class of antitumor ammine, amine, and imine complexes of Ru(II) and Ru(III), while the considered bases/ligands have been chosen as models for the main binding sites of DNA, nucleobases, and phosphate backbone and proteins, histidyl, and sulfur-containing residue such as methionine or cysteine. Bond dissociation enthalpies and free energies have been calculated for all the considered metal binding sites both in the gas phase and in solution and allow building a binding affinity order for the considered nucleic acid or protein binding sites. The binding of guanine to some bifunctional complexes, [Ru(NH3)(4)Cl2], [cis-RuCl(2)(bpy)2], and [cis-RuCl(2)(azpy)2], has also been considered to evaluate the effect of a second labile chloro or aquo ligand and more realistic polypyridyl and arylazopyridine ligands.